START MidWest — Grand Rapids, Michigan

START MidWest is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Clinical Trials Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

START MidWest has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Advanced Solid Tumors, Pancreatic Cancer, Non Small Cell Lung Cancer.

Sponsors: AstraZeneca, Asana BioSciences, Klus Pharma Inc..

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START MidWest?

START MidWest has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START MidWest conducted?

START MidWest has 5 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Tumors, Pancreatic Cancer, Non Small Cell Lung Cancer.

Is START MidWest accredited by Crixeo Clinical Trials?

START MidWest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START MidWest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.